Gallant CEO Dr. Linda Black Joins The Bird Bath to Discuss $18M Series B and the Future of Regenerative Medicine

Gallant CEO Dr. Linda Black was a featured guest on a special episode of The Bird Bath, a weekly news podcast covering innovation in pet health. Host Ryan Leech interviewed Dr. Black following Gallant’s $18 million Series B funding announcement.

From The Bird Bath
EXCLUSIVE: Gallant $18M Series B, FDA statements, Teacher’s Pet, and Relief Burnout

The episode covers Gallant’s vision for delivering ready-to-use, disease-modifying stem cell therapies to veterinary practices. Dr. Black explains how Gallant’s investigational product for FCGS may pave the way for a new category of regenerative therapies—while laying the regulatory foundation for a broader pipeline of uterine-derived stem cell treatments. She also reflects on the significance of the Series B raise, led by Digitalis Ventures and joined by NovaQuest and other strategic investors.